Lifecore Biomedical Inc
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Lifecore stock, expecting it to rise to a target price of $9.
Financial Health
Lifecore Biomedical is generating steady revenue and cash flow, but profitability is moderate.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring LFCR
Pharma's American Reshoring Wave
AstraZeneca is investing $50 billion to expand its U.S. manufacturing, partly in response to trade tariffs. This move could spark a wave of similar onshoring efforts, creating opportunities for companies that build, equip, and supply the growing domestic biopharmaceutical industry.
Published: July 23, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Dual Revenue Streams
Products and CDMO services give two potential growth levers, though performance can vary with customer demand and contract timing.
Manufacturing Edge
Specialist sterile-fill and HA expertise can attract OEM partners, but operations are capital and regulation intensive.
Market Exposure
Serves ophthalmic, orthopaedic and aesthetic markets with global opportunity, yet subject to regulatory and competitive headwinds.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
